$NBIS

Alonso Sanchez Maria del Dado sold $417K of NBIS

Alonso Sanchez Maria del Dado (CFO) sold 1,509 shares of Nebius Group N.V. (NBIS) at $276.20 ($0.42M total) on 2026-06-02.

Original reporting
SEC EDGAR · Alonso Sanchez Maria del Dado
Published Jun 3, 2026, 4:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 4:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NBIS
Neutral
medium confidence
Mentioned
$NBIS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NBISNeutralLow
01

Why it matters

The disclosed sale size (~1,509 shares) and price ($276.2002) may slightly affect sentiment, but it does not constitute new operational or financial information.

02

Market read

Traders may monitor for follow-on insider activity, but this filing alone is unlikely to drive a major repricing.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, which can increase scrutiny, but the article still lacks context (tax, diversification, liquidity needs).

Relevance 6/10Novelty 4/10Timing: Filed June 3; transaction executed June 2.

Background

SEC Form 4 reports insider transactions; this one is an open-market sale by the company’s CFO.

Company-level read

Ticker impact

$NBISNeutralMedium confidence
Context

Nebius Group CFO Alonso Sanchez Maria del Dado sold $416.8K of NBIS shares via an open-market transaction on June 2.

Expected impact

Likely limited near-term impact; treat as routine insider activity unless it repeats or is paired with other negative signals.

Evidence & confidence

Insider sales can be diversification/tax-driven; the filing provides transaction details but no new company-specific business development.

Market effects

No clear sector read-through from a single disclosed insider sale.

None indicated.

None indicated.

Counterpoint

If insider selling accelerates across multiple officers or coincides with other negative disclosures, it could signal rising risk appetite concerns.

Key entities

  • Nebius Group N.V.

    Subject of the Form 4 insider transaction disclosure.

  • Alonso Sanchez Maria del Dado

    CFO who sold 1,509 shares of NBIS for ~$416.8K.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NBISMed

Nebius stock breaks below $200 as CoreWeave’s debt scare spreads

Nebius Group (NBIS) fell 10.1% to $186.01 on October 14, 2026, breaking its $200 support level. The decline was driven by fears of excessive debt in the AI sector, sparked by CoreWeave (CRWV) bonds yielding near 15%. Nebius's funding costs may rise due to this market sentiment. The company's stock trades at 38x trailing sales and 7x forward sales, with analysts' price targets ranging from $84 to $410.

$NBISMed

Why is Nebius stock sliding today?

Nebius Group NV (NBIS) stock fell 4.1% to $178.4 in pre-open trading, extending losses due to rising borrowing costs, higher bond yields for peer CoreWeave, and Gartner's warning about AI infrastructure spending risks. Insider selling and a bearish stance from short-seller Michael Burry also contributed. The broader tech sector selloff, driven by higher Treasury yields, added pressure.

$NBISMed

Nebius Group (NBIS) Shares Drop 10% Amid Tech Sell-Off; P/S Rati

Nebius Group (NBIS) shares fell 10.08% to $186.01 on October 14, 2026, amid a broader tech sector sell-off. The company's P/S ratio is 38.39, significantly above its historical median and industry norms. Nebius has a GF Score of 52, with strong momentum but weak valuation and financial strength. Insiders have sold $318.2 million in shares over the past year, while some institutional investors have increased their stakes.